The Trump administration asked a federal judge on Monday to dismiss a lawsuit that drastically restricted access to access to the abortive pill Mifepristone, taking the same position as the administration biden in a case of close surveillance that has important implications for access to abortion.
The judicial presentation of the Department of Justice is surprising, since President Trump and several officials in his administration have opposed the force. Trump often boasts of that appointed three of the judges of the Supreme Court who voted in 2022 to cancel the national law to abortion. And so far in his second term, his administration has tasks to reduce programs that support reproductive health.
The presentation of the Court was the first time that the Trump administration intervened in the lawsuit, which seeks to reverse numerous regulatory changes carried out by the Food and Medicines Administration, as of 2016, which extended access to a large extent to Mifedristone.
The Trump administration application did not mention the merits of the case, which have not yet consulted their legs by the courts. Rather, echoing the argument that the Biden Administration became little before Mr. Trump Tok’s office, the presentation of the court states that the case does not meet the legal standard that will be heard in the Federal District Court in which it was presented.
The plaintiffs in the case are the conservative general prosecutors of three states: Missouri, Idaho and Kansas, and the case was presented in a Federal District Court in Texas.
“The states do not dispute that their claims have no connection with the northern district of Texas,” wrote the lawyers of the Department of Justice in the presentation.
“Regardless of the merits of the states,” states cannot process in this court, “they concluded, and added that the complaint” must be dismissed or transferred due to lack of place. “
The demand also requests new restrictions of the FDA in the Mifepristona, even to prohibit the medicine for any person under 18. And points the rapid growth practice to prescribe pills of abortive telehorticin pills and send them to patients.
The case was initially presented in 2022 by a consortium of doctors and anti -abortion groups and reached the Supreme Court. But in the unanimous ruling last June, the judges threw the case, saying that the plaintiffs had no position to sue because they could not prove that they had been harmed by the FDA decisions about Mifedristone.
A few months later, the three general prosecutors revived the lawsuit and filed a complaint amended as plaintiffs in the same Federal District Court in Texas. The judge in the case, Judge Matthew J. Kacsmaryk, of the United States District Court, for the Northern Texas District, a Trump Appaytee that opposes access to abortion, made decisions in the first iteration of the FDA framed framieuros anti -abortion activists.
Abortion pills are prescribed up to 12 weeks in pregnancy in the United States, and are now used in almost two thirds of abortions in the country. Women in states with abortion prohibitions have sought more and more abortion pills through telemedicine suppliers.
Currently, 19 states have more strict prohibitions or restrictions than the standard established by Roe v. Wade. In states that support abortion rights, telemedicine abortion suppliers have expanded, and several states have approved shield laws that protect doctors and other health suppliers that recipe and send abortive pills to patients in states or restrictions.
